SWOG 0514: a phase II study of sorafenib in patients with unresectable
- This topic has 0 replies, 1 voice, and was last updated 12 years, 9 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
http://www.springerlink.com/content/9424358gnh113p87/
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.